Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Stanek

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Chest|June 20, 2000
Prognostic value of hemodynamic vs big endothelin measurements during long-term IV therapy in advanced heart failure patientsB Frey, R Pacher, G Locker, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 13, 2001
Long-term effect of atenolol on ejection fraction, symptoms, and exercise variables in patients with advanced left ventricular dysfunctionM Hülsmann, B Sturm, R Pacher, et al.
Circulation|February 22, 2001
Effects of endothelin a receptor blockade on endothelial function in patients with chronic heart failureR Berger, B Stanek, M Hülsmann, et al.
Pacing and Clinical Electrophysiology : PACE|January 1, 1995
Sudden death and staged therapy for hemodynamic stabilization in patients enrolled in a heart transplantation programB Frey, M Wutte, R Berger, et al.
Wiener Klinische Wochenschrift|September 25, 1998
[Improved kidney function with intravenous prostaglandin E1 in patients with terminal heart failure]M Wutte, M Hülsmann, R Berger, et al.
Wiener Klinische Wochenschrift|February 24, 2001
[Heart transplantation: indications and guidelines]J Bergler-Klein, B Schlechta, B Stanek, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 16, 2001
B-type natriuretic peptides (BNP and PRO-BNP) predict longterm survival in patients with advanced heart failure treated with atenololR Berger, B Stanek, B Frey, et al.
European Journal of Clinical Investigation|December 21, 2004
Natriuretic peptides and the prevalence of congestive heart failure in patients with pacemakersM Gwechenberger, M Huelsmann, S Graf, et al.
Wiener Klinische Wochenschrift|April 11, 1997
Effects of atenolol as add-on therapy to fosinopril in heart failureR Pacher, M Hülsmann, R Berger, et al.
The Journal of Clinical Endocrinology and Metabolism|May 10, 2007
Insulin and insulin-like growth factor stimulation of vascular endothelial growth factor production by luteinized granulosa cells: comparison between polycystic ovarian syndrome (PCOS) and non-PCOS womenMeghan B Stanek, Sherri M Borman, Theodore A Molskness, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Chest|June 20, 2000
Prognostic value of hemodynamic vs big endothelin measurements during long-term IV therapy in advanced heart failure patientsB Frey, R Pacher, G Locker, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 13, 2001
Long-term effect of atenolol on ejection fraction, symptoms, and exercise variables in patients with advanced left ventricular dysfunctionM Hülsmann, B Sturm, R Pacher, et al.
Circulation|February 22, 2001
Effects of endothelin a receptor blockade on endothelial function in patients with chronic heart failureR Berger, B Stanek, M Hülsmann, et al.
Pacing and Clinical Electrophysiology : PACE|January 1, 1995
Sudden death and staged therapy for hemodynamic stabilization in patients enrolled in a heart transplantation programB Frey, M Wutte, R Berger, et al.
Wiener Klinische Wochenschrift|September 25, 1998
[Improved kidney function with intravenous prostaglandin E1 in patients with terminal heart failure]M Wutte, M Hülsmann, R Berger, et al.
Wiener Klinische Wochenschrift|February 24, 2001
[Heart transplantation: indications and guidelines]J Bergler-Klein, B Schlechta, B Stanek, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 16, 2001
B-type natriuretic peptides (BNP and PRO-BNP) predict longterm survival in patients with advanced heart failure treated with atenololR Berger, B Stanek, B Frey, et al.
European Journal of Clinical Investigation|December 21, 2004
Natriuretic peptides and the prevalence of congestive heart failure in patients with pacemakersM Gwechenberger, M Huelsmann, S Graf, et al.
Wiener Klinische Wochenschrift|April 11, 1997
Effects of atenolol as add-on therapy to fosinopril in heart failureR Pacher, M Hülsmann, R Berger, et al.
The Journal of Clinical Endocrinology and Metabolism|May 10, 2007
Insulin and insulin-like growth factor stimulation of vascular endothelial growth factor production by luteinized granulosa cells: comparison between polycystic ovarian syndrome (PCOS) and non-PCOS womenMeghan B Stanek, Sherri M Borman, Theodore A Molskness, et al.
Pageof 8